urea has been researched along with Sinus Tachycardia in 4 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Perioperative landiolol administration suppressed the incidence of new-onset of AF as well as sinus tachycardia, and the plasma IL-6 elevation in patients undergoing esophageal cancer surgery." | 9.24 | The suppressive effects of landiolol administration on the occurrence of postoperative atrial fibrillation and tachycardia, and plasma IL-6 elevation in patients undergoing esophageal surgery: A randomized controlled clinical trial. ( Goyagi, T; Horiguchi, T; Horikoshi, Y; Kodama, S; Kudo, R; Nishikawa, T, 2017) |
| "The use of landiolol hydrochloride for HR control of non-arrhythmic tachycardia in critically ill infants is well tolerated." | 8.31 | Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension. ( Ackerl, J; Dresbach, T; Kipfmueller, F; Monno, P; Mueller, A; Schmitt, J; Schroeder, L; Shatilova, O; Unger, M, 2023) |
| "The purpose of this study was to investigate the efficacy of landiolol hydrochloride, a short-acting beta(1) blocker, by initiating its administration at a low dose (5 microg kg(-1) min(-1)) in patients with postoperative supraventricular arrhythmia." | 7.75 | Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose. ( Fukutomi, T; Nishimori, H; Radhakrishnan, G; Sasaguri, S; Wariishi, S; Yamamoto, M; Yamashita, K, 2009) |
| "Perioperative landiolol administration suppressed the incidence of new-onset of AF as well as sinus tachycardia, and the plasma IL-6 elevation in patients undergoing esophageal cancer surgery." | 5.24 | The suppressive effects of landiolol administration on the occurrence of postoperative atrial fibrillation and tachycardia, and plasma IL-6 elevation in patients undergoing esophageal surgery: A randomized controlled clinical trial. ( Goyagi, T; Horiguchi, T; Horikoshi, Y; Kodama, S; Kudo, R; Nishikawa, T, 2017) |
| "The use of landiolol hydrochloride for HR control of non-arrhythmic tachycardia in critically ill infants is well tolerated." | 4.31 | Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension. ( Ackerl, J; Dresbach, T; Kipfmueller, F; Monno, P; Mueller, A; Schmitt, J; Schroeder, L; Shatilova, O; Unger, M, 2023) |
| "3 μg/kg/min (mean ± SD) landiolol with sinus tachycardia and received catecholamine therapy after on-pump cardiovascular surgery." | 3.91 | Use of low-dose β ( Jujo, S; Kamei, M; Kobayashi, J; Ohnishi, Y; Sakai, M, 2019) |
| "The purpose of this study was to investigate the efficacy of landiolol hydrochloride, a short-acting beta(1) blocker, by initiating its administration at a low dose (5 microg kg(-1) min(-1)) in patients with postoperative supraventricular arrhythmia." | 3.75 | Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose. ( Fukutomi, T; Nishimori, H; Radhakrishnan, G; Sasaguri, S; Wariishi, S; Yamamoto, M; Yamashita, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schroeder, L | 1 |
| Monno, P | 1 |
| Unger, M | 1 |
| Ackerl, J | 1 |
| Shatilova, O | 1 |
| Schmitt, J | 1 |
| Dresbach, T | 1 |
| Mueller, A | 1 |
| Kipfmueller, F | 1 |
| Horikoshi, Y | 1 |
| Goyagi, T | 1 |
| Kudo, R | 1 |
| Kodama, S | 1 |
| Horiguchi, T | 1 |
| Nishikawa, T | 1 |
| Sakai, M | 1 |
| Jujo, S | 1 |
| Kobayashi, J | 1 |
| Ohnishi, Y | 1 |
| Kamei, M | 1 |
| Wariishi, S | 1 |
| Yamashita, K | 1 |
| Nishimori, H | 1 |
| Fukutomi, T | 1 |
| Yamamoto, M | 1 |
| Radhakrishnan, G | 1 |
| Sasaguri, S | 1 |
1 trial available for urea and Sinus Tachycardia
| Article | Year |
|---|---|
The suppressive effects of landiolol administration on the occurrence of postoperative atrial fibrillation and tachycardia, and plasma IL-6 elevation in patients undergoing esophageal surgery: A randomized controlled clinical trial.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cytokines; Esophagea | 2017 |
3 other studies available for urea and Sinus Tachycardia
| Article | Year |
|---|---|
Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension.
Topics: Child; Critical Illness; Female; Heart Rate; Humans; Hypertension, Pulmonary; Infant; Infant, Newbor | 2023 |
Use of low-dose β
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiac Surgical Procedures; Catecholamines; Female; Heart | 2019 |
Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; | 2009 |